Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
Bacterial Vaginosis, Vulvovaginal Candidiasis
About this trial
This is an interventional basic science trial for Bacterial Vaginosis
Eligibility Criteria
Inclusion Criteria: Age 18-54 Female Pre-menopausal Can speak and read in English Displays capacity for informed consent Has had 2 or more documented and/or self-reported episodes of symptomatic BV or candida infection in the last year, requiring, over-the-counter or prescription treatment Exclusion Criteria: Pregnant or trying to become pregnant Post-menopausal Using NuvaRing device A past medical history of kidney disease, recurrent UTI, and/or urinary tract abnormalities Current UTI Using Phexxi as a contraceptive during the collection period of the study
Sites / Locations
- Queens Medical Center, 1004 Clinic POB1Recruiting
Arms of the Study
Arm 1
Experimental
Study group
This is a single-arm study. all participants are assigned to this arm. all study participants will receive Phexxi, the study drug. 8 pre-filled vaginal inserters with vaginal gel, Phexxi, will be provided to each of the participants with verbal and written instructions for application. Patients will be instructed to use Phexxi twice per week, on the same days every week.